$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Probiotics, gut microbiota and health
Probiotiques, microbiote intestinal et sante

Médecine et maladies infectieuses, v.44 no.1, 2014년, pp.1 - 8  

Butel, M.J.

Abstract AI-Helper 아이콘AI-Helper

The human gut is a huge complex ecosystem where microbiota, nutrients, and host cells interact extensively, a process crucial for the gut homeostasis and host development with a real partnership. The various bacterial communities that make up the gut microbiota have many functions including metaboli...

주제어

참고문헌 (66)

  1. Anonyme. Report of a joint FAO/WHO Expert Consultation. Health and nutritional properties of probiotics in food includion powder milk with live lactic acid bacteria. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf. Cordoba, Argentina, October 2001. 

  2. Anonyme. Report of a joint FAO/WHO Expert Consultation. Guidelines for the evaluation of probiotics in food. http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0282-tab-03-ref-19-joint-faowho-vol219.pdf. London, Canada, April 2002. 

  3. Appl Environ Microbiol Martin 75 965 2009 10.1128/AEM.02063-08 Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-DGGE and qRTi-PCR 

  4. J Pediatr Gastroenterol Nutr Maldonado 54 55 2012 10.1097/MPG.0b013e3182333f18 Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastro-intestinal and upper respiratory tract infections in infants 

  5. Am J Clin Nutr Boyle 83 1256 2006 10.1093/ajcn/83.6.1256 Probiotic use in clinical practice: what are the risks? 

  6. Nat Rev Immunol Round 9 313 2009 10.1038/nri2515 The gut microbiota shapes intestinal immune responses during health and disease 

  7. Appl Environ Microbiol Menard 74 660 2008 10.1128/AEM.01261-07 Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants 

  8. Eur J Clin Microbiol Infect Dis Cannon 24 31 2005 10.1007/s10096-004-1253-y Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases 

  9. Int J Food Microbiol Franz 151 125 2011 10.1016/j.ijfoodmicro.2011.08.014 Enterococci as probiotics and their implications in food safety 

  10. Clin Infect Dis Snydman 46 Suppl 2 S104 2008 10.1086/523331 The safety of probiotics 

  11. Clin Infect Dis Salminen 35 1155 2002 10.1086/342912 Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland 

  12. Intensive Care Med Lherm 28 797 2002 10.1007/s00134-002-1267-9 Seven cases of fungemia with Saccharomyces boulardii in critically ill patients 

  13. Eur J Clin Microbiol Infect Dis Hennequin 19 16 2000 10.1007/s100960050003 Possible role of catheters in Saccharomyces boulardii fungemia 

  14. J Pediatr Gastroenterol Nutr Connolly 41 489 2005 10.1097/01.mpg.0000176179.81638.45 Safety of D(-)-lactic acid producing bacteria in the human infant 

  15. Schjorring 2011 3129 2011 Assessment of bacterial antibiotic resistance transfer in the gut. Int J Microbiol 2011; 

  16. J Appl Microbiol Egervarn 107 1658 2009 10.1111/j.1365-2672.2009.04352.x Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum 

  17. Appl Environ Microbiol Aires 73 2751 2007 10.1128/AEM.02459-06 Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans 

  18. Antonie van Leeuwenhoek Egervarn 97 189 2010 10.1007/s10482-009-9401-0 Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastro-intestinal tract of humans 

  19. FEMS Microbiol Ecol Jacobsen 59 158 2007 10.1111/j.1574-6941.2006.00212.x Horizontal transfer of tet(M) and erm(B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastro-intestinal tract of gnotobiotic rats 

  20. Cochrane Database Syst Rev Allen CD003048 2010 Probiotics for treating acute infectious diarrhoea 

  21. Inflamm Allergy Drug Targets Salari 11 3 2012 10.2174/187152812798889394 A meta-analysis and systematic review on the effect of probiotics in acute diarrhea 

  22. Cochrane Database Syst Rev Bernaola CD007401 2010 Probiotics for treating persistent diarrhoea in children 

  23. Aliment Pharmacol Ther Szajewska 34 1079 2011 10.1111/j.1365-2036.2011.04837.x the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children 

  24. JAMA Hempel 307 1959 2012 10.1001/jama.2012.3507 Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis 

  25. Cochrane Database Syst Rev Goldenberg 5 CD006095 2013 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children 

  26. Diagn Microbiol Infect Dis Sha 75 245 2013 10.1016/j.diagmicrobio.2012.11.022 The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease 

  27. J Clin Gastroenterol Meijer 45 Suppl. S139 2011 10.1097/MCG.0b013e31822103f7 Probiotics in the treatment of human inflammatory bowel diseases: update 2011 

  28. Cochrane Database Syst Rev Butterworth CD006634 2008 Probiotics for induction of remission in Crohn's disease 

  29. Dig Dis Sci Rahimi 53 2524 2008 10.1007/s10620-007-0171-0 A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease 

  30. J Clin Gastroenterol Floch 45 Suppl. S168 2011 10.1097/MCG.0b013e318230928b Recommendations for probiotic use-2011 update 

  31. Nutrients Mack 3 245 2011 10.3390/nu3020245 Probiotics in inflammatory bowel diseases and associated conditions 

  32. Inflamm Bowel Dis Sokol 15 1183 2009 10.1002/ibd.20903 Low counts of Faecalibacterium prausnitzii in colitis microbiota 

  33. Microbiology Salonen 156 3205 2010 10.1099/mic.0.043257-0 Gastro-intestinal microbiota in irritable bowel syndrome: present state and perspectives 

  34. Expert Rev Gastroenterol Hepatol Almansa 6 383 2012 Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome 

  35. N Engl J Med Camilleri 367 1626 2012 10.1056/NEJMra1207068 Peripheral mechanisms in irritable bowel syndrome 

  36. Gut Moayyedi 59 325 2010 10.1136/gut.2008.167270 The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review 

  37. BMC Gastroenterol Hoveyda 9 15 2009 10.1186/1471-230X-9-15 A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome 

  38. J Hum Nutr Diet McKenzie 25 260 2012 10.1111/j.1365-277X.2012.01242.x British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults 

  39. Clin Exp Immunol Okada 160 1 2010 10.1111/j.1365-2249.2010.04139.x The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update 

  40. Waligora-Dupriet 413 2012 Allergic diseases-highlights in the clinic, mechanisms and treatment Microbiota and allergy: from dysbiosis to probiotics 

  41. Clin Exp Immunol Ozdemir 160 295 2010 10.1111/j.1365-2249.2010.04109.x Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data 

  42. Epidemiology Pelucchi 23 402 2012 10.1097/EDE.0b013e31824d5da2 Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis 

  43. Gut Malfertheiner 61 646 2012 10.1136/gutjnl-2012-302084 Management of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report 

  44. Aliment Pharmacol Ther Szajewska 32 1069 2010 10.1111/j.1365-2036.2010.04457.x the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment 

  45. Nature Turnbaugh 444 1027 2006 10.1038/nature05414 An obesity-associated gut microbiome with increased capacity for energy harvest 

  46. Nature Qin 490 55 2012 10.1038/nature11450 A metagenome-wide association study of gut microbiota in type 2 diabetes 

  47. Mol Aspects Med Shen 34 39 2013 10.1016/j.mam.2012.11.001 The gut microbiota, obesity and insulin resistance 

  48. Pharmacol Res Sanz 69 144 2013 10.1016/j.phrs.2012.10.021 Understanding the role of gut microbes and probiotics in obesity: how far are we? 

  49. Nature de Vos 498 48 2013 10.1038/nature12251 Genomics: A gut prediction 

  50. Cancer Lett Serban 2013 10.1016/j.canlet.2013.08.013 Gastro-intestinal cancers: influence of gut microbiota, probiotics and prebiotics 

  51. Cochrane Database Syst Rev Hao CD006895 2011 Probiotics for preventing acute upper respiratory tract infections 

  52. J Paediatr Child Health Williams 48 942 2012 10.1111/j.1440-1754.2012.02574.x Probiotics may prevent upper respiratory tract infections, but should we recommend them? 

  53. Gastroenterol Clin Biol Campeotto 31 533 2007 10.1016/S0399-8320(07)89424-3 [Establishment of the intestinal microflora in neonates] 

  54. J Pediatr Gastroenterol Nutr Rautava 38 378 2004 10.1097/00005176-200404000-00004 The hygiene hypothesis of atopic disease - an extended version 

  55. Arch Dis Child Laubereau 89 993 2004 10.1136/adc.2003.043265 Caesarean section and gastro-intestinal symptoms, atopic dermatitis, and sensitisation during the first year of life 

  56. Arch Dis Child Huh 2012 10.1136/archdischild-2011-301141 Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study 

  57. Acta Paediatr Suppl Agosti 91 44 2003 10.1111/j.1651-2227.2003.tb00645.x Allergic manifestations in very low-birthweight infants: a 6-year follow-up 

  58. Inflamm Bowel Dis Schippa 15 661 2009 10.1002/ibd.20818 Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease 

  59. Clin Infect Dis Finegold 35 S6 2002 10.1086/341914 Gastro-intestinal microflora studies in late-onset autism 

  60. Diabetologia Cardwell 51 726 2008 10.1007/s00125-008-0941-z Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies 

  61. J Pediatr Gastroenterol Nutr Braegger 52 238 2011 10.1097/MPG.0b013e3181fb9e80 Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition 

  62. JAMA Dermatol Foolad 149 350 2013 10.1001/jamadermatol.2013.1495 Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids 

  63. Cochrane Database Syst Rev Boyle CD006135 2008 Probiotics for treating eczema 

  64. Int J Obes (Lond) Luoto 34 1531 2010 10.1038/ijo.2010.50 The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years 

  65. Cochrane Database Syst Rev Alfaleh CD005496 2011 Probiotics for prevention of necrotizing enterocolitis in preterm infants 

  66. BMC Med Deshpande 9 92 2011 10.1186/1741-7015-9-92 Evidence-based guidelines for use of probiotics in preterm neonates 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로